|
Jun 30
|
Karolinska Development divests shares in portfolio company OssDsign
|
|
Jun 27
|
Karolinska Development's portfolio company Modus Therapeutics carries out a fully secured rights issue of SEK 28.3 million
|
|
Jun 4
|
Karolinska Development’s portfolio company OssDsign raises approximately SEK 158 million, announces an updated strategy and revises financial targets
|
|
Feb 14
|
Year-end Report - January-December 2024
|